We found that hepatic FXR protein and mRNA levels were downregulated in T2DM+CUMS groups of mice, while the protein of SHP, the target gene of FXR, in the liver, was not significantly different among the T2DM and T2DM+CUMS groups. This evidence concerns the gene NR1H4 and type 2 diabetes mellitus.